Publication
Cardiovascular risk in HIV-infected individuals : a comparison of three risk prediction algorithms
| dc.contributor.author | Policarpo, Sara | |
| dc.contributor.author | Rodrigues, Teresa | |
| dc.contributor.author | Moreira, Ana Catarina | |
| dc.contributor.author | Valadas, Emília | |
| dc.date.accessioned | 2020-11-19T11:26:21Z | |
| dc.date.available | 2020-11-19T11:26:21Z | |
| dc.date.issued | 2019 | |
| dc.description | © 2019 Published by Elsevier España, S.L.U. on behalf of Sociedade Portuguesa de Cardiologia. This is an open access article under CC BY-NC-ND license. (http://creativecommons.org/licenses/by-nc-nd/4.0/) | pt_PT |
| dc.description.abstract | Introduction: Cardiovascular (CV) risk is known to be increased in HIV-infected individuals. Our aim was to assess CV risk in HIV-infected adults. Methods: CV risk was estimated for each patient using three different risk algorithms: SCORE, the Framingham risk score (FRS), and DAD. Patients were classified as at low, moderate or high CV risk. Clinical and anthropometric data were collected. Results: We included 571 HIV-infected individuals, mostly male (67.1%; n=383). Patients were divided into two groups according to antiretroviral therapy (ART): naïve (7.5%; n=43) or under ART (92.5%; n=528). The mean time since HIV diagnosis was 6.7±6.5 years in the naive group and 13.3±6.1 years in the ART group. Metabolic syndrome (MS) was identified in 33.9% (n=179) and 16.3% (n=7) of participants in the ART and naïve groups, respectively. MS was associated with ART (OR=2.7; p=0.018). Triglycerides ≥150 mg/dl (OR=13.643, p<0.001) was one of the major factors contributing to MS. Overall, high CV risk was found in 4.4% (n=23) of patients when the SCORE tool was used, in 20.5% (n=117) using the FRS, and in 10.3% (n=59) using the DAD score. The observed agreement between the FRS and SCORE was 55.4% (k=0.183, p<0.001), between the FRS and DAD 70.5% (k=0.465, p<0.001), and between SCORE and DAD 72.3% (k=0.347, p<0.001). Conclusion: On the basis of the three algorithms, we detected a high rate of high CV risk, particularly in patients under ART. The FRS was the algorithm that classified most patients in the high CV risk category (20.5%). In addition, a high prevalence of MS was identified in this patient group. | pt_PT |
| dc.description.version | info:eu-repo/semantics/publishedVersion | pt_PT |
| dc.identifier.citation | Rev Port Cardiol. 2019 Jul;38(7):463-470 | pt_PT |
| dc.identifier.doi | 10.1016/j.repc.2019.08.002 | pt_PT |
| dc.identifier.eissn | 2174-2030 | |
| dc.identifier.issn | 0870-2551 | |
| dc.identifier.uri | http://hdl.handle.net/10451/44931 | |
| dc.language.iso | eng | pt_PT |
| dc.peerreviewed | yes | pt_PT |
| dc.publisher | Elsevier | pt_PT |
| dc.relation.publisherversion | https://www.sciencedirect.com/journal/revista-portuguesa-de-cardiologia | pt_PT |
| dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/4.0/ | pt_PT |
| dc.subject | Cardiovascular risk | pt_PT |
| dc.subject | HIV/Acquired immunodeficiency syndrome | pt_PT |
| dc.subject | Metabolic syndrome | pt_PT |
| dc.subject | Portugal | pt_PT |
| dc.title | Cardiovascular risk in HIV-infected individuals : a comparison of three risk prediction algorithms | pt_PT |
| dc.title.alternative | Risco cardiovascular em infetados por VIH : comparação de três ferramentas de avaliação | pt_PT |
| dc.type | journal article | |
| dspace.entity.type | Publication | |
| oaire.citation.endPage | 470 | pt_PT |
| oaire.citation.issue | 7 | pt_PT |
| oaire.citation.startPage | 463 | pt_PT |
| oaire.citation.title | Revista Portuguesa de Cardiologia | pt_PT |
| oaire.citation.volume | 38 | pt_PT |
| person.familyName | Policarpo | |
| person.familyName | Moreira | |
| person.familyName | Valadas | |
| person.givenName | Sara | |
| person.givenName | Ana Catarina | |
| person.givenName | Emília | |
| person.identifier.ciencia-id | C81E-CC41-DFB0 | |
| person.identifier.orcid | 0000-0001-8594-1720 | |
| person.identifier.orcid | 0000-0001-7031-6738 | |
| person.identifier.orcid | 0000-0001-5213-1473 | |
| person.identifier.scopus-author-id | 16234261500 | |
| person.identifier.scopus-author-id | 6603593138 | |
| rcaap.rights | openAccess | pt_PT |
| rcaap.type | article | pt_PT |
| relation.isAuthorOfPublication | 18ef9bc3-1f7a-414b-b2aa-a1163f2f2367 | |
| relation.isAuthorOfPublication | 99a1310a-f2d3-4b0d-b756-706d04fc29fa | |
| relation.isAuthorOfPublication | 5eb6f5fc-a01f-4938-832e-bad672e8c877 | |
| relation.isAuthorOfPublication.latestForDiscovery | 5eb6f5fc-a01f-4938-832e-bad672e8c877 |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- HIV_infected_individuals.pdf
- Size:
- 908.12 KB
- Format:
- Adobe Portable Document Format
